Polymer nanocarriers for the delivery of small fragments of nucleic acids: Oligonucleotides and siRNA

被引:87
作者
de Martimprey, H. [2 ]
Vauthier, C.
Malvy, C. [2 ]
Couvreur, P. [1 ]
机构
[1] Univ Paris Sud, CNRS, UMR 8612, F-92296 Chatenay Malabry, France
[2] Inst Gustave Roussy, Villejuif, France
关键词
Nanocarriers; Nanoparticles; Polymer micelles; Nanocapsules; RNA interference; RNAi; siRNA; Oligonucleotides; ODN; DOUBLE-STRANDED-RNA; CATIONIC FUSOGENIC PEPTIDE; IN-VIVO; ANTISENSE OLIGONUCLEOTIDES; MESSENGER-RNA; GENE DELIVERY; NONVIRAL DELIVERY; INTERFERING RNA; PLASMID DNA; POLYALKYLCYANOACRYLATE NANOPARTICLES;
D O I
10.1016/j.ejpb.2008.09.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The success of the application of new therapeutic methods based on RNA interfering strategies requires the in vivo delivery of active ODN or siRNA down to the intracellular compartment of the target cells. This article aims to review the studies related to the formulation of RNA interfering agents in polymer nanocarriers. It will present the different types of polymer nanocarriers used as well as the biological activity of the resulting ODN and siRNA loaded nanocarriers. As will be explained, the part of the in vitro studies provided useful data about the intracellular delivery of the formulated RNA interfering agents. Investigations performed in vivo have considered animal models of different relevant diseases. Results from these investigations have clearly demonstrated the interest of several polymer nanocarriers tested so far to deliver active RNA interfering effectors in vivo making possible their administration by the intravenous route. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:490 / 504
页数:15
相关论文
共 119 条
[51]   SUBACUTE AND CHRONIC TOXICITY OF CETYLTRIMETHYLAMMONIUM BROMIDE (CTAB), A CATIONIC SURFACTANT, IN RAT [J].
ISOMAA, B ;
REUTER, J ;
DJUPSUND, BM .
ARCHIVES OF TOXICOLOGY, 1976, 35 (02) :91-96
[52]   Exploiting the enhanced permeability and retention effect for tumor targeting [J].
Iyer, Arun K. ;
Khaled, Greish ;
Fang, Jun ;
Maeda, Hiroshi .
DRUG DISCOVERY TODAY, 2006, 11 (17-18) :812-818
[53]  
JAHRAUS A, 1994, J CELL SCI, V107, P145
[54]   A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles [J].
Jeong, JH ;
Kim, SW ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 2003, 93 (02) :183-191
[55]   Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide [J].
Jeong, JH ;
Kim, SW ;
Park, TG .
BIOCONJUGATE CHEMISTRY, 2003, 14 (02) :473-479
[56]   PDMAEMA is internalised by endocytosis but does not physically disrupt endosomes [J].
Jones, RA ;
Poniris, MH ;
Wilson, MR .
JOURNAL OF CONTROLLED RELEASE, 2004, 96 (03) :379-391
[57]   Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(L-lysine):: A potential carrier for systemic delivery of antisense DNA [J].
Kakizawa, Y ;
Harada, A ;
Kataoka, K .
BIOMACROMOLECULES, 2001, 2 (02) :491-497
[58]   Development and characterisation of chitosan nanoparticles for siRNA delivery [J].
Katas, Haliza ;
Alpar, H. Oya .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (02) :216-225
[59]   Strategies for silencing human disease using RNA interference [J].
Kim, Daniel H. ;
Rossi, John J. .
NATURE REVIEWS GENETICS, 2007, 8 (03) :173-184
[60]   PEG conjugated VEGF siRNA for anti-angiogenic gene therapy [J].
Kim, Sun Hwa ;
Jeong, Ji Hoon ;
Lee, Soo Hyun ;
Kim, Sung Wan ;
Park, Tae Gwan .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (02) :123-129